FDA Timeline for Density Notification
JoAnn Pushkin
Executive Director at DenseBreast-info, Inc. || The World's Leading Website About Dense Breasts
The process for a single national "dense breast" reporting standard is a process that began over 10 years ago with my written request to the FDA to consider inclusion of density information in the lay letter. I and other advocates testified at the 2011 National Mammography Quality Assurance Advisory Committee meeting where consensus?was?reached that density?should?be included in the lay letter. The 38 states with existing inform laws provide varying levels of notification. A single national reporting standard would mean all American women receive equal information about the screening and risk implications of dense tissue and provide for equal opportunity to discuss supplemental screening leading to earlier detection.?
Today U.S. Congresswoman Rosa DeLauro announced a timeline has been secured from the FDA on the rollout for the updated FDA reporting requirement. We are nearing the finish line! Learn more here: https://delauro.house.gov/media-center/press-releases/delauro-secures-timeline-fda-rollout-breast-density-notification-rule
Senior Regional Sales Account Executive at iCAD, Inc.
2 年????????????????thank you JoAnn and all involved for your dedication??
Senior Clinical Specialist Automated Breast Ultrasound at GEHC
2 年So exciting!! Thanks for all your teams hard work JoAnn!!
Strategic Consultant, Advisor, Founder. Ancillary Service Additions and Medical Practice Enhancement Specialities. Early Breast Cancer Detection Imaging and Services are my passion.
2 年A Win For All Women!
Huge admiration for what has been achieved to date and all the best for the final step. Love your graphic!
Health Equity for Women; Medical Device CEO of DeepLook Medical; Nonprofit CEO of HERhealthEQ; Co-Chair US AI for Good; Investment Committee at Goddess Gaia Ventures; EIR at Graybella Capital; TEDx Speaker.
2 年Absolutely amazing!!! Can't wait to see it over the finish line.